Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Disease Control Priorities, Third Edition (Volume 4)
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-being of individuals, families, and societies is large, growing, and underestimated. Despite this burden, these disorders have been systematically neglected, particularly in low- and middle-income countries, with pitifully small contributions to scaling up cost-effective prevention and treatment strategies. Systematically compiling the substantial existing knowledge to address this inequity is the central goal of this volume. This evidence-base can help policy makers in resource-constrained settings as they prioritize programs and interventions to address these disorders.
Atlas
Neurological disorders, such as strokes, multiple sclerosis, epilepsy, dementia and Parkinson's disease, constitute a large and increasing share of the global burden of disease. This WHO publication brings together a wide range of information on neurological resources across 109 countries, with the participation of leading experts in neurology. The information is arranged under 15 broad themes and topics covered include: common neurological conditions and services in primary care and specialist settings; therapeutic drugs and services; number and types of health professionals; postgraduate teaching; financing issues and disability benefits; and the advocacy role of national associations and non-governmental organisations. The report highlights the fact that the available resources for neurological services in most countries are insufficient compared with the global need for neurological care; as well as the significant inequalities in resources across regions and income groups within countries.
Neurological Disorders
Although there are several gaps in understanding the many issues related to neurological disorders, we know enough to be able to shape effective policy responses to some of the most common. This book describes and discusses the increasing public health impact of common neurological disorders such as dementia, epilepsy, headache disorders, multiple sclerosis, neuroinfections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson's disease, stroke and traumatic brain injuries. It provides information and advice on public health interventions that may reduce their occurrence and consequences, and offers health professionals and planners the opportunity to assess the burden caused by these disorders. The clear message that emerges is that unless immediate action is taken globally, the neurological burden is likely to become an increasingly serious and unmanageable.
Disease Control Priorities, Third Edition (Volume 7)
At the turn of the millennium, the world experienced a dramatic increase in funding for global health programs. Competing demands for these resources meant that policymakers needed access to valid, evidence-based information on the costs and consequences of a broad range of health interventions. By providing systematic and comparable information about purchasing health in LMICs, Disease Control Priorities in Developing Countries, Second Edition greatly informed and enriched these conversations and we hope -- improved resource allocations. Nearly ten years later, increased attention to chronic diseases and the importance of health systems in providing access to quality care is once again resh...
Atlas
Multiple sclerosis (MS) is one of the most common neurological disorders and causes of disability in young adults. Although some people with MS experience little disability during their lifetime, up to 60% are no longer fully ambulatory 20 years after onset, with major implications for their quality of life and the financial cost to society. This new publication from the World Health Organization and the Multiple Sclerosis International Federation (MSIF) presents evidence on the global epidemiology of multiple sclerosis and the resources to diagnose, treat, rehabilitate, support and provide services to people with MS. Atlas-MS summarizes information from 112 countries, representing 88% of the global population, thus can be considered as the leading global assessment on multiple sclerosis. The results of the survey reveal a lack of services and resources allocated to the care of people with MS. The situation is of particular concern in most low and middle income countries.
Defeating meningitis by 2030
The vision of the Defeating meningitis by 2030 global road map is “Towards a world free of meningitis” carried by three visionary goals: i) elimination of bacterial meningitis epidemics, ii) reduction of cases of vaccine-preventable bacterial meningitis by 50% and deaths by 70%, and iii) reduction of disability and improvement of quality of life after meningitis. The global road map, developed through iterative multidisciplinary consultations, paves the way to achieve this. It has been approved by the Seventy-Third World Health Assembly in November 2020.
